BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 1705190)

  • 1. Histochemical localization of calcium with potassium pyroantimonate in the articular tissues in calcium pyrophosphate dihydrate crystal deposition disease.
    Ohira T; Ishikawa K
    Clin Orthop Relat Res; 1991 Mar; (264):286-94. PubMed ID: 1705190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A histologic and immunohistochemical study of calcium pyrophosphate dihydrate crystal deposition disease.
    Masuda I; Ishikawa K; Usuku G
    Clin Orthop Relat Res; 1991 Feb; (263):272-87. PubMed ID: 1993383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic localization of lipid in the articular tissues in calcium pyrophosphate dihydrate crystal deposition disease.
    Ohira T; Ishikawa K; Masuda I; Yokoyama M; Honda I
    Arthritis Rheum; 1988 Aug; 31(8):1057-62. PubMed ID: 2457374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cartilage intermediate layer protein expression in calcium pyrophosphate dihydrate crystal deposition disease.
    Yamakawa K; Iwasaki H; Masuda I; Ohjimi Y; Honda I; Iyama K; Shono E; Naito M; Kikuchi M
    J Rheumatol; 2002 Aug; 29(8):1746-53. PubMed ID: 12180739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.
    Hirose J; Ryan LM; Masuda I
    Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A histological study of calcium pyrophosphate dihydrate crystal-deposition disease.
    Ishikawa K; Masuda I; Ohira T; Yokoyama M
    J Bone Joint Surg Am; 1989 Jul; 71(6):875-86. PubMed ID: 2545720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium pyrophosphate crystal deposition in hyaline cartilage. Ultrastructural analysis and implications for pathogenesis.
    Pritzker KP; Cheng PT; Renlund RC
    J Rheumatol; 1988; 15(5):828-35. PubMed ID: 2845077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ultrastructural study of the articular cartilage in calcium pyrophosphate dihydrate (CPPD) crystal deposition disease (chondrocalcinosis articularis).
    Bjelle AO; Sundström KG
    Calcif Tissue Res; 1975 Nov; 19(1):63-71. PubMed ID: 172199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of the crystals observed in the destructive arthropathies of chondrocalcinosis].
    Gaucher A; Faure G; Netter P; Pourel J; Duheille J
    Rev Rhum Mal Osteoartic; 1977 Jun; 44(6):407-14. PubMed ID: 882816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of alizarin red s staining in calcium pyrophosphate dihydrate crystal deposition disease.
    Yamakawa K; Iwasaki H; Masuda I; Ohjimi Y; Honda I; Saeki K; Zhang J; Shono E; Naito M; Kikuchi M
    J Rheumatol; 2003 May; 30(5):1032-5. PubMed ID: 12734902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of calcium-containing crystals to cartilage degradation and synovial inflammation in osteoarthritis.
    Liu YZ; Jackson AP; Cosgrove SD
    Osteoarthritis Cartilage; 2009 Oct; 17(10):1333-40. PubMed ID: 19447216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of ANK protein expression in joint tissue in calcium pyrophosphate dihydrate crystal deposition disease.
    Uzuki M; Sawai T; Ryan LM; Rosenthal AK; Masuda I
    J Rheumatol; 2014 Jan; 41(1):65-74. PubMed ID: 24293574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Scanning electron microscopic observations of calcium pyrophosphate crystals of joint tissues and synovial fluid (author's transl)].
    Nagahashi M
    Nihon Seikeigeka Gakkai Zasshi; 1979 Jul; 53(7):793-805. PubMed ID: 227973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium pyrophosphate crystal deposition disease and other crystal deposition diseases.
    Fam AG
    Curr Opin Rheumatol; 1992 Aug; 4(4):574-82. PubMed ID: 1503884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium pyrophosphate dihydrate-crystal induced arthropathy].
    Schneider Internist-Rheumatologe Chefarzt Der Abteilung Für Rheumatologie P; Schneider I
    Z Rheumatol; 2004 Feb; 63(1):10-21. PubMed ID: 14991274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypomagnesemia and chondrocalcinosis in short bowel syndrome.
    Richette P; Ayoub G; Bardin T; Bouvet S; Orcel P; Badran AM
    J Rheumatol; 2005 Dec; 32(12):2434-6. PubMed ID: 16331778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of crystals within the joint.
    Oliviero F; Scanu A; Punzi L
    Reumatismo; 2012 Jan; 63(4):221-9. PubMed ID: 22303528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of alkaline phosphatase by cysteine: implications for calcium pyrophosphate dihydrate crystal deposition disease.
    So PP; Tsui FW; Vieth R; Tupy JH; Pritzker KP
    J Rheumatol; 2007 Jun; 34(6):1313-22. PubMed ID: 17516619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chondrocalcinosis].
    Fallet GH; Vischer TL; Micheli A
    Schweiz Med Wochenschr; 1982 Jun; 112(25):888-97. PubMed ID: 7112058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferrous [Fe++] but not ferric [Fe] ions inhibit de novo formation of calcium pyrophosphate dihydrate crystals: possible relationships to chondrocalcinosis and hemochromatosis.
    Cheng PT; Pritzker KP
    J Rheumatol; 1988 Feb; 15(2):321-4. PubMed ID: 2834554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.